Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 2Phase 3 2Phase 1/2 1Phase 1 1

Status

Recruiting 3Not yet recruiting 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5

Conditions

Carcinoma, Non-Small-Cell Lung 226Breast Neoplasms 223Prostatic Neoplasms 163Multiple Myeloma 147Neoplasms 130Leukemia, Myeloid, Acute 117Colorectal Neoplasms 117Lung Neoplasms 112Neoplasm Metastasis 95Squamous Cell Carcinoma of Head and Neck 90Carcinoma, Hepatocellular 88Melanoma 83Lymphoma 81Triple Negative Breast Neoplasms 74Pancreatic Neoplasms 73Ovarian Neoplasms 72Sarcoma 66Lymphoma, Large B-Cell, Diffuse 63Carcinoma, Renal Cell 63Brain Neoplasms 62Recurrence 58Head and Neck Neoplasms 57Stomach Neoplasms 54Precursor Cell Lymphoblastic Leukemia-Lymphoma 54Leukemia, Lymphocytic, Chronic, B-Cell 53Urinary Bladder Neoplasms 52Hematologic Neoplasms 52Lymphoma, Non-Hodgkin 51Small Cell Lung Carcinoma 50Endometrial Neoplasms 47

Interventions

Radiosurgery 2toripalimab 1cemiplimab 1Radiotherapy 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × NSCLC × 90 days × Clear all
NCT07379398 2026-04-29

Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Not yet recruiting
28 enrolled
Thoracic

NSCLC

NCT07550920 2026-04-24

Relatrilfa-α Plus Single-Agent Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III NSCLC (Phase 2)

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Not yet recruiting
18 enrolled
Thoracic

NSCLC

NCT06865339 2026-04-13

TRIPL

Montefiore Medical Center

Phase 2 Recruiting
76 enrolled
Thoracic

NSCLC

NCT06738160 2026-03-20

The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer

Fudan University

Phase 2 Recruiting
27 enrolled
Thoracic

NSCLC

NCT05798845 2026-03-11

The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer

Shanghai Chest Hospital

Phase 2 Recruiting
124 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡